Answer ALS and Cedars-Sinai have announced the completed availability of the largest ALS patient-based iPSC and bio data ...
Mori Arkin's appointment as interim CEO as of January 1, 2025 approved by shareholdersPhase 3 clinical trial of SGT-610 for Gorlin Syndrome is ongoing with over 40 clinical sites activatedSGT-210 proo ...